Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2024 Jan 11;15(1):421.
doi: 10.1038/s41467-023-44676-z.

Autonomous artificial intelligence increases screening and follow-up for diabetic retinopathy in youth: the ACCESS randomized control trial

Affiliations
Randomized Controlled Trial

Autonomous artificial intelligence increases screening and follow-up for diabetic retinopathy in youth: the ACCESS randomized control trial

Risa M Wolf et al. Nat Commun. .

Abstract

Diabetic retinopathy can be prevented with screening and early detection. We hypothesized that autonomous artificial intelligence (AI) diabetic eye exams at the point-of-care would increase diabetic eye exam completion rates in a racially and ethnically diverse youth population. AI for Children's diabetiC Eye ExamS (NCT05131451) is a parallel randomized controlled trial that randomized youth (ages 8-21 years) with type 1 and type 2 diabetes to intervention (autonomous artificial intelligence diabetic eye exam at the point of care), or control (scripted eye care provider referral and education) in an academic pediatric diabetes center. The primary outcome was diabetic eye exam completion rate within 6 months. The secondary outcome was the proportion of participants who completed follow-through with an eye care provider if deemed appropriate. Diabetic eye exam completion rate was significantly higher (100%, 95%CI: 95.5%, 100%) in the intervention group (n = 81) than the control group (n = 83) (22%, 95%CI: 14.2%, 32.4%)(p < 0.001). In the intervention arm, 25/81 participants had an abnormal result, of whom 64% (16/25) completed follow-through with an eye care provider, compared to 22% in the control arm (p < 0.001). Autonomous AI increases diabetic eye exam completion rates in youth with diabetes.

PubMed Disclaimer

Conflict of interest statement

M.D.A. reports the following conflicts of interest: Investor, Director, Consultant, Digital Diagnostics Inc., Coralville, Iowa, USA; patents and patent applications assigned to the University of Iowa and Digital Diagnostics that are relevant to the subject matter of this manuscript; Chair Healthcare AI Coalition, Washington DC; member, American Academy of Ophthalmology (AAO) AI Committee; member, AI Workgroup Digital Medicine Payment Advisory Group (DMPAG); member, Collaborative Community for Ophthalmic Imaging (CCOI), Washington DC; Chair, Foundational Principles of AI CCOI Workgroup. R.M.W. reports receiving research support from Boehringer Ingelheim and Novo Nordisk outside the submitted work. The remaining authors declare no competing interests.

Figures

Fig. 1
Fig. 1
Flow diagram of patient enrollment and randomization in the ACCESS study (Based on CONSORT guideline 2010 flow diagram).

References

    1. Centers for Disease Control and Prevention Diabetes and Vision Losshttps://www.cdc.gov/diabetes/managing/diabetes-vision-loss.html (December 19, 2022).
    1. Zhang X, et al. Prevalence of diabetic retinopathy in the United States, 2005-2008. JAMA. 2010;304:649–656. doi: 10.1001/jama.2010.1111. - DOI - PMC - PubMed
    1. Zhang X, et al. Vision health disparities in the United States by race/ethnicity, education, and economic status: findings from two nationally representative surveys. Am. J. Ophthalmol. 2012;154:S53–62.e51. doi: 10.1016/j.ajo.2011.08.045. - DOI - PMC - PubMed
    1. Hale NL, Bennett KJ, Probst JC. Diabetes care and outcomes: disparities across rural America. J. Community Health. 2010;35:365–374. doi: 10.1007/s10900-010-9259-0. - DOI - PubMed
    1. Hill-Briggs F, et al. Social determinants of health and diabetes: a scientific review. Diabetes Care. 2020;44:258–279. doi: 10.2337/dci20-0053. - DOI - PMC - PubMed

Publication types